---
title: "Drug Resistance and Tolerance sometimes overcome by vitamin D supplementation"
slug: "drug-resistance-and-tolerance-sometimes-overcome-by-vitamin-d-supplementation"
aliases:
  - "/Drug+Resistance+and+Tolerance+sometimes+overcome+by+vitamin+D+supplementation+-+Oct+2024"
  - "/15754"
tiki_page_id: 15754
date: 2025-01-04
---


{{< toc >}}

---

#### Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions

Volume 2024, Article ID 9978076, 16 pages https://doi.org/10.1155/2024/9978076

Digvijaya,1 Saurabh Mittal©,2 Prateek Mittal,3 Ruhi Singh,2 Simran Gupta,2 Taniya Singh,2 Rahmuddin Khan©,4 Nafaa Alzobaidi ,5 and Abdulsalam Alhalmi 6

The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. 

Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures.

 **Conclusion (from PDF)** 

Various studies have been conducted to date which report and support the role of vitamin D in the etiology of several chronic disorders. Where the deficiency of vitamin D is found to increase the risk of worsening of the disease, supplementation with adequate doses of the vitamin is found to ameliorate the symptoms associated with the chronic disorder. Vitamin D is found to be effective in preventing the pathogenesis of  **depression**  and various studies have sup­ported its presence and role in the pathophysiology of major depression. Also, its role as an adjuvant to the drugs such as fluoxetine is proved by the studies, so we believe and suggest exploring its role in reversing drug tolerance. Moreover, various types of  **cancerous cell lines**  with resistance to one or the other anticancer drugs have proved to regain sensitivity for the drugs when treated with vitamin D. Some studies also suspect the role of vitamin D in TB and several microbial infections and opens the way to further research studies to investigate the reversal of drug resistance. One of the most important challenges faced by clinicians in the pharmaco­logical treatment of chronic ailments is the long-term use of the drugs which possibly leads to drug resistance and tol­erance and hence failure of the drug therapy.

Also, vitamin D deficiency is associated with almost every chronic disorder; so it can be concluded and hypothesized from the above- mentioned studies that vitamin D may also find its role in preventing the occurrence or reversing the mechanism of drug resistance and tolerance. 

The studies also reported the superiority of pharmacological treatment when combined with vitamin D supplements in comparison to the drugs administered alone. Further high-quality research is re­quired to find the role of vitamin D supplementation in preventing drug resistance and tolerance.

There are a number of options to investigate in order to better understand how vitamin D works therapeutically to fight drug resistance and to choose the best way to use it. One possible experimental strategy is to use cell lines in vitro to study the molecular mechanisms, such as how vitamin D affects drug efflux pumps or drug metabolic pathways. The in vivo benefits of vitamin D could be further investigated through animal experiments that utilize models of drug- resistant illnesses. Vitamin D supplementation in patients undergoing conventional pharmacological treatments and  . . . . .12 studies examining the advantages of vitamin D in con­junction with current treatments are two examples of crucial clinical trials that must be conducted. Pharmacogenomic research has the potential to uncover genetic markers that indicate how a person will react to vitamin D, which could lead to more targeted approaches to treatment. Utilizing patient samples to investigate vitamin D metabolism and receptor expression, translational research might center on gaining molecular knowledge of vitamin D’s impact on drug-resistant illnesses. If these methods work together, we may learn more about vitamin D’s function in fighting drug resistance and find better ways to use it therapeutically in the clinic.

 **<i class="fas fa-file-pdf" style="margin-right: 0.3em;"></i><a href="https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/d-and-drug-resistance-compresspdf.pdf">Download the PDF from VitaminDWiki </a>** 

---

#### Related studies in VitaminDWiki

* <a href="/posts/chemotherapy-and-vitamin-d-many-studies" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Chemotherapy and vitamin D - many studies">Chemotherapy and vitamin D - many studies</a>

* <a href="/posts/hypertension-not-reduced-by-drugs-resistant-hypertension-in-patients-with-low-vitamin-d" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D">Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D</a>

* <a href="/posts/vitamin-d-fights-treatment-resistant-cancers-petrie-dish" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019">Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019</a>

* <a href="/posts/tuberculosis-multi-drug-resistant-was-134-x-more-likely-to-be-quickly-cleared-wi-d-meta-analysis" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019">Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019</a>

* <a href="/posts/vitamin-d-fights-treatment-resistant-cancers-petrie-dish" style="color: red; text-decoration: underline;" title="This post/category does not exist yet: Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019">Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019</a>

<pre style="background-color: #e0e0e0; white-space: pre-wrap;">
<code class="language-text">
Markdown:
--------
{{&lt; toc &gt;}}

---

#### Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions

Volume 2024, Article ID 9978076, 16 pages https://doi.org/10.1155/2024/9978076

Digvijaya,1 Saurabh Mittal©,2 Prateek Mittal,3 Ruhi Singh,2 Simran Gupta,2 Taniya Singh,2 Rahmuddin Khan©,4 Nafaa Alzobaidi ,5 and Abdulsalam Alhalmi 6

The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. 

Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures.

 **Conclusion (from PDF)** 

Various studies have been conducted to date which report and support the role of vitamin D in the etiology of several chronic disorders. Where the deficiency of vitamin D is found to increase the risk of worsening of the disease, supplementation with adequate doses of the vitamin is found to ameliorate the symptoms associated with the chronic disorder. Vitamin D is found to be effective in preventing the pathogenesis of  **depression**  and various studies have sup­ported its presence and role in the pathophysiology of major depression. Also, its role as an adjuvant to the drugs such as fluoxetine is proved by the studies, so we believe and suggest exploring its role in reversing drug tolerance. Moreover, various types of  **cancerous cell lines**  with resistance to one or the other anticancer drugs have proved to regain sensitivity for the drugs when treated with vitamin D. Some studies also suspect the role of vitamin D in TB and several microbial infections and opens the way to further research studies to investigate the reversal of drug resistance. One of the most important challenges faced by clinicians in the pharmaco­logical treatment of chronic ailments is the long-term use of the drugs which possibly leads to drug resistance and tol­erance and hence failure of the drug therapy.

Also, vitamin D deficiency is associated with almost every chronic disorder; so it can be concluded and hypothesized from the above- mentioned studies that vitamin D may also find its role in preventing the occurrence or reversing the mechanism of drug resistance and tolerance. 

The studies also reported the superiority of pharmacological treatment when combined with vitamin D supplements in comparison to the drugs administered alone. Further high-quality research is re­quired to find the role of vitamin D supplementation in preventing drug resistance and tolerance.

There are a number of options to investigate in order to better understand how vitamin D works therapeutically to fight drug resistance and to choose the best way to use it. One possible experimental strategy is to use cell lines in vitro to study the molecular mechanisms, such as how vitamin D affects drug efflux pumps or drug metabolic pathways. The in vivo benefits of vitamin D could be further investigated through animal experiments that utilize models of drug- resistant illnesses. Vitamin D supplementation in patients undergoing conventional pharmacological treatments and  . . . . .12 studies examining the advantages of vitamin D in con­junction with current treatments are two examples of crucial clinical trials that must be conducted. Pharmacogenomic research has the potential to uncover genetic markers that indicate how a person will react to vitamin D, which could lead to more targeted approaches to treatment. Utilizing patient samples to investigate vitamin D metabolism and receptor expression, translational research might center on gaining molecular knowledge of vitamin D’s impact on drug-resistant illnesses. If these methods work together, we may learn more about vitamin D’s function in fighting drug resistance and find better ways to use it therapeutically in the clinic.

 **&lt;i class=&quot;fas fa-file-pdf&quot; style=&quot;margin-right: 0.3em;&quot;&gt;&lt;/i&gt;&lt;a href=&quot;https://d1bk1kqxc0sym.cloudfront.net/attachments/pdf/d-and-drug-resistance-compresspdf.pdf&quot;&gt;Download the PDF from VitaminDWiki &lt;/a&gt;** 

---

#### Related studies in VitaminDWiki

* &lt;a href=&quot;/posts/chemotherapy-and-vitamin-d-many-studies&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Chemotherapy and vitamin D - many studies&quot;&gt;Chemotherapy and vitamin D - many studies&lt;/a&gt;

* &lt;a href=&quot;/posts/hypertension-not-reduced-by-drugs-resistant-hypertension-in-patients-with-low-vitamin-d&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D&quot;&gt;Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D&lt;/a&gt;

* &lt;a href=&quot;/posts/vitamin-d-fights-treatment-resistant-cancers-petrie-dish&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019&quot;&gt;Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019&lt;/a&gt;

* &lt;a href=&quot;/posts/tuberculosis-multi-drug-resistant-was-134-x-more-likely-to-be-quickly-cleared-wi-d-meta-analysis&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019&quot;&gt;Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019&lt;/a&gt;

* &lt;a href=&quot;/posts/vitamin-d-fights-treatment-resistant-cancers-petrie-dish&quot; style=&quot;color: red; text-decoration: underline;&quot; title=&quot;This post/category does not exist yet: Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019&quot;&gt;Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019&lt;/a&gt;

AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions`
│   inner_content: `Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions`
│   │   inner_content: `Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions`├── TextNode
│   full_match: `\nVolume 2024, Article ID 9978076, 16 pages https://doi.org/10.1155/2024/9978076\nDigvijaya,1 Saurabh Mittal©,2 Prateek Mittal,3 Ruhi Singh,2 Simran Gupta,2 Taniya Singh,2 Rahmuddin Khan©,4 Nafaa Alzobaidi ,5 and Abdulsalam Alhalmi 6\n\nThe issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. \nVitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures.\n`
│   inner_content: `\nVolume 2024, Article ID 9978076, 16 pages https://doi.org/10.1155/2024/9978076\nDigvijaya,1 Saurabh Mittal©,2 Prateek Mittal,3 Ruhi Singh,2 Simran Gupta,2 Taniya Singh,2 Rahmuddin Khan©,4 Nafaa Alzobaidi ,5 and Abdulsalam Alhalmi 6\n\nThe issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. \nVitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures.\n`├── BoldNode
│   full_match: `__Conclusion (from PDF)__`
│   inner_content: `Conclusion (from PDF)`
│   children:
│   ├── TextNode
│   │   full_match: `Conclusion (from PDF)`
│   │   inner_content: `Conclusion (from PDF)`├── TextNode
│   full_match: `\nVarious studies have been conducted to date which report and support the role of vitamin D in the etiology of several chronic disorders. Where the deficiency of vitamin D is found to increase the risk of worsening of the disease, supplementation with adequate doses of the vitamin is found to ameliorate the symptoms associated with the chronic disorder. Vitamin D is found to be effective in preventing the pathogenesis of `
│   inner_content: `\nVarious studies have been conducted to date which report and support the role of vitamin D in the etiology of several chronic disorders. Where the deficiency of vitamin D is found to increase the risk of worsening of the disease, supplementation with adequate doses of the vitamin is found to ameliorate the symptoms associated with the chronic disorder. Vitamin D is found to be effective in preventing the pathogenesis of `├── BoldNode
│   full_match: `__depression__`
│   inner_content: `depression`
│   children:
│   ├── TextNode
│   │   full_match: `depression`
│   │   inner_content: `depression`├── TextNode
│   full_match: ` and various studies have sup­ported its presence and role in the pathophysiology of major depression. Also, its role as an adjuvant to the drugs such as fluoxetine is proved by the studies, so we believe and suggest exploring its role in reversing drug tolerance. Moreover, various types of `
│   inner_content: ` and various studies have sup­ported its presence and role in the pathophysiology of major depression. Also, its role as an adjuvant to the drugs such as fluoxetine is proved by the studies, so we believe and suggest exploring its role in reversing drug tolerance. Moreover, various types of `├── BoldNode
│   full_match: `__cancerous cell lines__`
│   inner_content: `cancerous cell lines`
│   children:
│   ├── TextNode
│   │   full_match: `cancerous cell lines`
│   │   inner_content: `cancerous cell lines`├── TextNode
│   full_match: ` with resistance to one or the other anticancer drugs have proved to regain sensitivity for the drugs when treated with vitamin D. Some studies also suspect the role of vitamin D in TB and several microbial infections and opens the way to further research studies to investigate the reversal of drug resistance. One of the most important challenges faced by clinicians in the pharmaco­logical treatment of chronic ailments is the long-term use of the drugs which possibly leads to drug resistance and tol­erance and hence failure of the drug therapy.\nAlso, vitamin D deficiency is associated with almost every chronic disorder; so it can be concluded and hypothesized from the above- mentioned studies that vitamin D may also find its role in preventing the occurrence or reversing the mechanism of drug resistance and tolerance. \nThe studies also reported the superiority of pharmacological treatment when combined with vitamin D supplements in comparison to the drugs administered alone. Further high-quality research is re­quired to find the role of vitamin D supplementation in preventing drug resistance and tolerance.\nThere are a number of options to investigate in order to better understand how vitamin D works therapeutically to fight drug resistance and to choose the best way to use it. One possible experimental strategy is to use cell lines in vitro to study the molecular mechanisms, such as how vitamin D affects drug efflux pumps or drug metabolic pathways. The in vivo benefits of vitamin D could be further investigated through animal experiments that utilize models of drug- resistant illnesses. Vitamin D supplementation in patients undergoing conventional pharmacological treatments and  . . . . .12 studies examining the advantages of vitamin D in con­junction with current treatments are two examples of crucial clinical trials that must be conducted. Pharmacogenomic research has the potential to uncover genetic markers that indicate how a person will react to vitamin D, which could lead to more targeted approaches to treatment. Utilizing patient samples to investigate vitamin D metabolism and receptor expression, translational research might center on gaining molecular knowledge of vitamin D’s impact on drug-resistant illnesses. If these methods work together, we may learn more about vitamin D’s function in fighting drug resistance and find better ways to use it therapeutically in the clinic.\n\n`
│   inner_content: ` with resistance to one or the other anticancer drugs have proved to regain sensitivity for the drugs when treated with vitamin D. Some studies also suspect the role of vitamin D in TB and several microbial infections and opens the way to further research studies to investigate the reversal of drug resistance. One of the most important challenges faced by clinicians in the pharmaco­logical treatment of chronic ailments is the long-term use of the drugs which possibly leads to drug resistance and tol­erance and hence failure of the drug therapy.\nAlso, vitamin D deficiency is associated with almost every chronic disorder; so it can be concluded and hypothesized from the above- mentioned studies that vitamin D may also find its role in preventing the occurrence or reversing the mechanism of drug resistance and tolerance. \nThe studies also reported the superiority of pharmacological treatment when combined with vitamin D supplements in comparison to the drugs administered alone. Further high-quality research is re­quired to find the role of vitamin D supplementation in preventing drug resistance and tolerance.\nThere are a number of options to investigate in order to better understand how vitamin D works therapeutically to fight drug resistance and to choose the best way to use it. One possible experimental strategy is to use cell lines in vitro to study the molecular mechanisms, such as how vitamin D affects drug efflux pumps or drug metabolic pathways. The in vivo benefits of vitamin D could be further investigated through animal experiments that utilize models of drug- resistant illnesses. Vitamin D supplementation in patients undergoing conventional pharmacological treatments and  . . . . .12 studies examining the advantages of vitamin D in con­junction with current treatments are two examples of crucial clinical trials that must be conducted. Pharmacogenomic research has the potential to uncover genetic markers that indicate how a person will react to vitamin D, which could lead to more targeted approaches to treatment. Utilizing patient samples to investigate vitamin D metabolism and receptor expression, translational research might center on gaining molecular knowledge of vitamin D’s impact on drug-resistant illnesses. If these methods work together, we may learn more about vitamin D’s function in fighting drug resistance and find better ways to use it therapeutically in the clinic.\n\n`├── FontNode
│   full_match: `{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}`
│   inner_content: `__{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   attrs_dict:
│   │   raw_content: size=&quot;17&quot;
│   │   size: 17
│   children:
│   ├── BoldNode
│   │   full_match: `__{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__`
│   │   inner_content: `{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   children:
│   │   ├── AttachNode
│   │   │   full_match: `{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}`
│   │   │   inner_content: `Download the PDF from VitaminDWiki `
│   │   │   attrs_dict:
│   │   │   │   raw_content: (inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)
│   │   │   │   inline: 1
│   │   │   │   id: 22151
│   │   │   │   icon: 1
│   │   │   children:
│   │   │   ├── TextNode
│   │   │   │   full_match: `Download the PDF from VitaminDWiki `
│   │   │   │   inner_content: `Download the PDF from VitaminDWiki `├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!Related studies in VitaminDWiki`
│   inner_content: `Related studies in VitaminDWiki`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `Related studies in VitaminDWiki`
│   │   inner_content: `Related studies in VitaminDWiki`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `* ((Chemotherapy and vitamin D - many studies))`
│   inner_content: ` ((Chemotherapy and vitamin D - many studies))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Chemotherapy and vitamin D - many studies))`
│   │   inner_content: `Chemotherapy and vitamin D - many studies`
│   │   page: `Chemotherapy and vitamin D - many studies`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Chemotherapy and vitamin D - many studies`
│   │   │   inner_content: `Chemotherapy and vitamin D - many studies`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D))`
│   inner_content: `((Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D))`
│   │   inner_content: `Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D`
│   │   page: `Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D`
│   │   │   inner_content: `Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   inner_content: `((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   │   inner_content: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   page: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   │   inner_content: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019))`
│   inner_content: `((Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019))`
│   │   inner_content: `Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019`
│   │   page: `Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019`
│   │   │   inner_content: `Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   inner_content: `((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   depth: `1`
│   children:
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))`
│   │   inner_content: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   page: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`
│   │   │   inner_content: `Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019`

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!Vitamin D Fortification: A Promising Approach to Overcome Drug Resistance and Tolerance in Therapeutic Interventions
Volume 2024, Article ID 9978076, 16 pages https://doi.org/10.1155/2024/9978076
Digvijaya,1 Saurabh Mittal©,2 Prateek Mittal,3 Ruhi Singh,2 Simran Gupta,2 Taniya Singh,2 Rahmuddin Khan©,4 Nafaa Alzobaidi ,5 and Abdulsalam Alhalmi 6

The issue of drug resistance and tolerance presents a significant challenge as it diminishes the efficacy and potency of medications, posing a formidable obstacle for physicians striving to enhance pharmacological therapy worldwide. These resistance mechanisms can arise from genetic predispositions or as a consequence of medical interventions. Notably, acquired resistance or tolerance may extend to other drugs within the same or different classes, despite differing mechanisms of action. This phenomenon leads to the ineffectiveness of various pharmacological treatments over time, hindering the attainment of complete remission for numerous illnesses spanning metabolic disorders, autoimmune diseases, carcinomas, infectious diseases, cardiovascular diseases, and neurological disorders. 
Vitamin D, an essential lipid-soluble nutrient crucial for regulating calcium and phosphorus levels, is emerging as a potential solution to counteract treatment resistance and tolerance in various conditions such as cancer, tuberculosis, and depression. This review scrutinizes existing research and offers insights for future investigations aimed at fully elucidating the therapeutic potential of vitamin D in mitigating the challenges associated with prolonged medication regimens and drug treatment failures.
__Conclusion (from PDF)__
Various studies have been conducted to date which report and support the role of vitamin D in the etiology of several chronic disorders. Where the deficiency of vitamin D is found to increase the risk of worsening of the disease, supplementation with adequate doses of the vitamin is found to ameliorate the symptoms associated with the chronic disorder. Vitamin D is found to be effective in preventing the pathogenesis of __depression__ and various studies have sup­ported its presence and role in the pathophysiology of major depression. Also, its role as an adjuvant to the drugs such as fluoxetine is proved by the studies, so we believe and suggest exploring its role in reversing drug tolerance. Moreover, various types of __cancerous cell lines__ with resistance to one or the other anticancer drugs have proved to regain sensitivity for the drugs when treated with vitamin D. Some studies also suspect the role of vitamin D in TB and several microbial infections and opens the way to further research studies to investigate the reversal of drug resistance. One of the most important challenges faced by clinicians in the pharmaco­logical treatment of chronic ailments is the long-term use of the drugs which possibly leads to drug resistance and tol­erance and hence failure of the drug therapy.
Also, vitamin D deficiency is associated with almost every chronic disorder; so it can be concluded and hypothesized from the above- mentioned studies that vitamin D may also find its role in preventing the occurrence or reversing the mechanism of drug resistance and tolerance. 
The studies also reported the superiority of pharmacological treatment when combined with vitamin D supplements in comparison to the drugs administered alone. Further high-quality research is re­quired to find the role of vitamin D supplementation in preventing drug resistance and tolerance.
There are a number of options to investigate in order to better understand how vitamin D works therapeutically to fight drug resistance and to choose the best way to use it. One possible experimental strategy is to use cell lines in vitro to study the molecular mechanisms, such as how vitamin D affects drug efflux pumps or drug metabolic pathways. The in vivo benefits of vitamin D could be further investigated through animal experiments that utilize models of drug- resistant illnesses. Vitamin D supplementation in patients undergoing conventional pharmacological treatments and  . . . . .12 studies examining the advantages of vitamin D in con­junction with current treatments are two examples of crucial clinical trials that must be conducted. Pharmacogenomic research has the potential to uncover genetic markers that indicate how a person will react to vitamin D, which could lead to more targeted approaches to treatment. Utilizing patient samples to investigate vitamin D metabolism and receptor expression, translational research might center on gaining molecular knowledge of vitamin D’s impact on drug-resistant illnesses. If these methods work together, we may learn more about vitamin D’s function in fighting drug resistance and find better ways to use it therapeutically in the clinic.

{FONT(size=&quot;17&quot;)}__{ATTACH(inline=&quot;1&quot; id=&quot;22151&quot; icon=&quot;1&quot;)}Download the PDF from VitaminDWiki {ATTACH}__{FONT}
---
!!!!Related studies in VitaminDWiki
* ((Chemotherapy and vitamin D - many studies))
*((Hypertension not reduced by drugs (Resistant Hypertension) in patients with low vitamin D))
*((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))
*((Tuberculosis (multi-drug resistant) was 13.4 X more likely to be quickly cleared with Vitamin D - Meta-analysis Feb 2019))
*((Vitamin D fights treatment-resistant cancers (petrie dish) – June 2019))
</code>
</pre>
